+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tacrolimus"

Tacrolimus Market Report, Global, 2024 - Product Thumbnail Image

Tacrolimus Market Report, Global, 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
From
Organ Transplant Immunosuppressant Drugs Market Report 2025 - Product Thumbnail Image

Organ Transplant Immunosuppressant Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Systemic Lupus Erythematosus Drugs Market 2025-2033 - Product Thumbnail Image

Systemic Lupus Erythematosus Drugs Market 2025-2033

  • Report
  • March 2025
  • 144 Pages
  • Global
From
From
Graft versus host disease (GvHD) - Pipeline Insight, 2024 - Product Thumbnail Image

Graft versus host disease (GvHD) - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 180 Pages
  • Global
From
From
Vitiligo Pipeline Analysis Report - Product Thumbnail Image

Vitiligo Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
Immunosuppressants Global Market Report 2024 - Product Thumbnail Image

Immunosuppressants Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Atopic Dermatitis Drugs Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Atopic Dermatitis Drugs Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 143 Pages
  • Global
From
From
Lung transplant rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Lung transplant rejection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
From
From
Loading Indicator

Tacrolimus is an immunosuppressant drug used to treat immune disorders such as rheumatoid arthritis, psoriasis, and Crohn's disease. It works by inhibiting the production of certain proteins that are involved in the body's immune response. Tacrolimus is typically administered orally or intravenously, and is available in both generic and branded forms. It is also used to prevent organ rejection in transplant patients. Tacrolimus is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other drugs. It is generally well tolerated, with few side effects. However, it can cause serious side effects, such as an increased risk of infection and an increased risk of developing certain types of cancer. The tacrolimus market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, and Sanofi. Other companies include Mylan, Teva, and Sun Pharmaceuticals. Show Less Read more